MedTrace Logo

Breath Condensate Study in Patients With Cystic Fibrosis.

NCT02056132 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-08-25

No results posted yet for this study

Summary

There is an urgent need for a noninvasive method to diagnose bronchial infections and exacerbations in patients with Cystic Fibrosis (CF). The current method to diagnosed infections involves either collecting a sputum sample or obtaining a bronchoalveolar lavage (BAL). However, some patients cannot produce sputum. At the same time the decision of when a patient has an exacerbation continues to be very subjective. In this exploratory study, we propose a new, noninvasive method to diagnose bronchial infections and to evaluate possible markers of inflammation that can assist in a noninvasive way in the determination of exacerbations.

Conditions

Interventions

OTHER

Exhaled Breath Condensate

Lab results of Exhaled Breath Condensate

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Jorge Lascano, MD · University of Florida

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2023-08-22
Completion
2023-08-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02056132 on ClinicalTrials.gov